Richard L. Gulino Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard L. Gulino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard L. Gulino. Richard L. Gulino is SVP & General Counsel in Vanda Pharmaceuticals Inc. ($VNDA) and SVP, General Counsel & Sec. in Vanda Pharmaceuticals Inc. ($VNDA) and CLO, GC & Corp Sec in InterDigital, Inc. ($IDCC).
Latest Insider Trading Transactions of Richard L. Gulino
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 02 2021 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 6,620 | 0 | 16,083 | 9.5 K to 16.1 K (+69.96 %) |
Jan 29 2021 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 38 | 0 | 9,463 | 9.4 K to 9.5 K (+0.40 %) |
Jul 24 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 43 | 0 | 9,380 | 9.3 K to 9.4 K (+0.46 %) |
Jun 17 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Sell | D | 55.38 | 929 | 51,448 | 9,337 | 10.3 K to 9.3 K (-9.05 %) |
Jun 17 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Sell | D | 55.38 | 929 | 51,448 | 9,337 | 10.3 K to 9.3 K (-9.05 %) |
Jun 17 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 3,030 | 0 | 10,266 | 7.2 K to 10.3 K (+41.87 %) |
Jun 17 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 3,030 | 0 | 10,266 | 7.2 K to 10.3 K (+41.87 %) |
Apr 24 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 16 | 0 | 7,236 | 7.2 K to 7.2 K (+0.22 %) |
Jan 24 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 6 | 0 | 2,178 | 2.2 K to 2.2 K (+0.28 %) |
Jan 16 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 1,210 | 0 | 2,172 | 962 to 2.2 K (+125.78 %) |
Jan 16 2020 | IDCC | InterDigital, Inc. | Gulino Richard L. | CLO, GC & Corp Sec | Grant | A | 0.00 | 1,210 | 0 | 2,172 | 962 to 2.2 K (+125.78 %) |
Mar 02 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Option Exercise | A | 18.85 | 70,000 | 1,319,500 | 70,000 | |
Mar 02 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Sell | S | 18.71 | 3,660 | 68,473 | 115,073 | 118.7 K to 115.1 K (-3.08 %) |
Mar 02 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Grant | A | 0.00 | 30,000 | 0 | 118,733 | 88.7 K to 118.7 K (+33.81 %) |
Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Option Exercise | M | 0.00 | 7,500 | 0 | 15,000 | |
Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Option Exercise | M | 0.00 | 12,500 | 0 | 25,000 | |
Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Sell | S | 15.20 | 10,367 | 157,565 | 88,733 | 99.1 K to 88.7 K (-10.46 %) |
Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Buy | M | 0.00 | 7,500 | 0 | 99,100 | 91.6 K to 99.1 K (+8.19 %) |
Jan 04 2018 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Buy | M | 0.00 | 12,500 | 0 | 76,600 | 64.1 K to 76.6 K (+19.50 %) |
Mar 03 2017 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Option Exercise | A | 14.50 | 70,000 | 1,015,000 | 70,000 | |
Mar 03 2017 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Grant | A | 0.00 | 30,000 | 0 | 39,100 | 9.1 K to 39.1 K (+329.67 %) |
Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Sell | S | 15.51 | 10,900 | 169,090 | 9,100 | 20 K to 9.1 K (-54.50 %) |
Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Buy | M | 0.00 | 7,500 | 0 | 20,000 | 12.5 K to 20 K (+60.00 %) |
Jan 05 2017 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP, General Counse ... | Buy | M | 0.00 | 12,500 | 0 | 12,500 | 0 to 12.5 K |
Feb 17 2016 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP & General Couns ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 17 2016 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP & General Couns ... | Option Exercise | A | 7.94 | 70,000 | 555,800 | 70,000 | |
Sep 15 2015 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP & General Couns ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Sep 15 2015 | VNDA | Vanda Pharmaceutic ... | Gulino Richard L. | SVP & General Couns ... | Option Exercise | A | 13.26 | 150,000 | 1,989,000 | 150,000 |
Page: 1